A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
about
A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancerShedding new light on neurodegenerative diseases through the mammalian target of rapamycinMetabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cellsClinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancerMicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets.Rapamycin selectively reduces the association of transcripts containing complex 5' UTRs with ribosomes in C4-2B prostate cancer cells.Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.Discovering modulators of gene expression.Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action.Androgen receptors beyond prostate cancer: an old marker as a new target.Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groupsEndostatin: A novel inhibitor of androgen receptor function in prostate cancer.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.Sex differences and sex steroids in lung health and disease.Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancerAndrogens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptorDAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferationThe Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth.TRPV1 activation impedes foam cell formation by inducing autophagy in oxLDL-treated vascular smooth muscle cells.Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men.Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives.The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma.ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling.Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.Adenosine A1-Receptors Modulate mTOR Signaling to Regulate White Matter Inflammatory Lesions Induced by Chronic Cerebral Hypoperfusion.Noxin promotes proliferation of breast cancer cells via P38-ATF2 signaling pathway.Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers.Androgen pathway manipulation and survival in patients with lung cancer.Production of amphiregulin and recovery from influenza is greater in males than females.Androgen excess in pancreatic β cells and neurons predisposes female mice to type 2 diabetes
P2860
Q26740327-0F44D5EB-C70B-471A-98B3-EFC5B804AC68Q27015640-8581544B-36B1-4C10-B93A-03263BBE2868Q28479062-11425202-1EE1-4A7C-9593-BADF4BD80F1DQ33389676-4CFF34D8-8F3A-44F1-88D2-E983B33359ACQ33815996-D220DE9F-7750-49EF-AC30-2C3C19483064Q34033097-F3B47F5D-9488-49AE-85D1-DCA0AB1D397BQ34122589-4CCA0049-4B72-401B-8387-165C7E071501Q34146422-222DE3F3-FBB3-4161-86FF-59B7F8D1B55AQ34368433-B2A83A8C-4719-4A3E-B64D-3B1E0B5C6523Q34458538-67209853-E1C6-4BE5-83E4-19F9996FD1D6Q34542337-067DCC3F-53B2-46B3-AB33-603E13579262Q35062621-CADC1EDC-590C-4471-B603-1C3D0B657CA4Q35157985-D1CB9DE8-8A72-40E4-B9A6-8B4C5AEBC146Q35776234-9CD6DBDE-BBD9-42B7-A1C3-DD5D825EE5D3Q36003356-29AD82F9-2CE7-4A74-B130-3DD6DE48C4BAQ36298306-664D446B-5CA2-4A91-A5C9-8BAD9F8954EAQ37022250-D2348207-1838-4D07-BDC8-58E5D5770FF9Q37062022-7AD8466F-6772-495F-8515-582686598894Q37513919-523482B8-F288-46C0-9785-4489EEA43E44Q37627154-257265BE-0A69-4FCA-8C5A-E855B4F73714Q37726111-8354CA9B-5006-4954-BFEF-FE32455DBEA8Q38944742-3030D1E9-0C05-4902-BC98-85236E871D31Q39285589-7F862CBA-82D8-459B-9875-579442056BFCQ39607971-CA29D9E5-F063-47B4-BF95-4BF1B5AA8464Q47116694-820012A5-3D25-4416-84AC-A655620B0B94Q47217714-01DBA296-2D06-4597-B1E4-00E8CFEDB0BCQ48497214-F4D20220-49A1-4E0D-855B-6C913BBFE3A0Q50942692-8B40662B-3FDC-400F-9E3E-9E97A661B62EQ51663124-BDA165FF-402D-465B-9356-EF1DD21DA536Q53576123-08E32473-ABEE-4B32-97BF-B11E6B6EBBB4Q55715145-908A938D-FA65-4D60-A4B0-D1CFF8867C7DQ58822197-1128A564-B561-4BEE-895F-437EFB0C5E4D
P2860
A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A cross-talk between the andro ...... rostate and lung cancer cells.
@en
A cross-talk between the andro ...... rostate and lung cancer cells.
@nl
type
label
A cross-talk between the andro ...... rostate and lung cancer cells.
@en
A cross-talk between the andro ...... rostate and lung cancer cells.
@nl
prefLabel
A cross-talk between the andro ...... rostate and lung cancer cells.
@en
A cross-talk between the andro ...... rostate and lung cancer cells.
@nl
P2093
P50
P1476
A cross-talk between the andro ...... prostate and lung cancer cells
@en
P2093
Ermanna Turano
Maria Luisa Panno
Rachele Zumpano
Sebastiano Andò
P304
P356
10.1016/J.BIOCEL.2008.07.004
P577
2008-07-23T00:00:00Z